Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL23R | Q5VWK5 | 12/20 | 0.48 |
| ▸ | TFPI | P10646 | 1/20 | 0.46 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31670607 | 0.88 | TFPI (0.49) | IL23RTFPIRXFP1 | |
| SCHEMBL29987871 | 0.88 | KEAP1 (0.45) | IL23RTFPI | |
| SCHEMBL30519038 | 0.86 | NMT1 (0.42) | — | |
| SCHEMBL29575493 | 0.85 | TFPI (0.46) | IL23RTFPIRXFP1 | |
| SCHEMBL31589116 | 0.85 | NMT1 (0.41) | TFPI | |
| SCHEMBL30788358 | 0.84 | IL23R (0.47) | IL23RTFPIRXFP1 | |
| SCHEMBL29736292 | 0.84 | OPRL1 (0.45) | — | |
| SCHEMBL30974329 | 0.83 | FOLH1 (0.42) | — | |
| SCHEMBL31737509 | 0.83 | IL23R (0.45) | IL23R | |
| SCHEMBL29591757 | 0.83 | QRFPR (0.44) | IL23RTFPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629405-B2 | Ezrin peptide 1 for use in a method of treating COVID-19 | PANTAPHARM AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-20240226231-A1 | EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING COVID-19 | PANTAPHARM AG (DE) | 2024-07-11 | — | — | US | disclosed |
| US-20240180999-A1 | EZRIN PEPTIDE 1 FOR USE IN A METHOD OF TREATING POST COVID-19 | PANTAPHARM AG (DE) | 2024-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629405-B2 | Ezrin peptide 1 for use in a method of treating COVID-19 | EZR, SARS1, SEPTIN2 | IL23R 2498/4885TFPI 1557/4885RXFP1 446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.